Provider Briefing: Acetaminophen/Caffeine Availability in 2026

Patients are increasingly asking their healthcare providers about difficulty finding over-the-counter medications — and Acetaminophen/Caffeine (Excedrin Tension Headache and generics) is no exception. While this OTC combination remains widely available nationally, localized stock-outs and patient confusion about product equivalence create real clinical touchpoints.

This briefing covers the current supply status, relevant prescribing considerations, and practical tools to help your patients access the medications they need.

Current Supply Timeline

Acetaminophen/Caffeine (500 mg/65 mg) is an OTC analgesic combination that does not require a prescription. Here's the supply picture:

• 2020-2021: During the COVID-19 pandemic, single-ingredient acetaminophen products experienced brief demand-driven shortages. Combination products (including Acetaminophen/Caffeine) were less affected but occasionally difficult to find.
• 2022-2024: Supply stabilized. Multiple generic manufacturers entered or expanded production. No FDA-listed shortages for oral Acetaminophen/Caffeine formulations.
• 2025-2026: No current shortage. The product is manufactured by Haleon (Excedrin brand), Perrigo, Major Pharmaceuticals, Strive Pharmaceuticals, and multiple store-brand producers. Distribution is broad across retail, pharmacy, and online channels.

Note on IV acetaminophen: Injectable acetaminophen (Ofirmev) has experienced intermittent shortages since 2023, with Hikma and other manufacturers reporting back-orders. This is a hospital supply issue and does not affect OTC oral products.

Prescribing Implications

While Acetaminophen/Caffeine is available OTC, there are clinical scenarios where provider guidance adds value:

Patient Populations to Consider

• Patients who cannot take NSAIDs: Acetaminophen/Caffeine is aspirin-free, making it an appropriate recommendation for patients with NSAID contraindications (GI bleeding history, renal impairment, cardiovascular risk).
• Pregnant patients: Acetaminophen is generally preferred over NSAIDs during pregnancy. However, caffeine intake should be discussed — the 65 mg per dose is approximately equivalent to one cup of coffee. Current guidance suggests limiting total caffeine to 200 mg/day during pregnancy.
• Patients at risk for acetaminophen toxicity: Emphasize the importance of checking all medications for acetaminophen content. Many combination products (cold/flu medications, prescription opioid combinations) contain acetaminophen. The maximum daily dose is 3,000 mg for the general population and should be lower for patients with hepatic impairment or alcohol use disorder.
• Patients with chronic headache: Frequent use of Acetaminophen/Caffeine (more than 2-3 days per week) can contribute to medication overuse headache. This is a common and underdiagnosed condition. Consider preventive migraine therapy for patients using OTC analgesics regularly.

Caffeine Considerations

The caffeine component (65 mg per dose, up to 195 mg at max daily dosing of 3 doses) is clinically relevant for:

• Patients with anxiety disorders or insomnia
• Patients taking other caffeine-containing medications or supplements
• Patients with cardiac arrhythmias or tachycardia
• Patients on medications with caffeine interactions (lithium, fluoroquinolones, theophylline)

Availability Picture

Acetaminophen/Caffeine is manufactured by multiple companies and available through diverse channels:

• Brand name: Excedrin Tension Headache (Haleon) — caplets and orally disintegrating tablets
• Major generics: Perrigo, Major Pharmaceuticals, Strive Pharmaceuticals
• Store brands: Equate (Walmart), Up & Up (Target), CVS Health, Walgreens, Kroger
• Online: Amazon, Walmart.com, CVS.com, Walgreens.com

Available dosage forms include standard caplets/tablets (500 mg/65 mg and 325 mg/65 mg) and orally disintegrating tablets (500 mg/65 mg).

Cost and Access Considerations

As an OTC product, Acetaminophen/Caffeine does not require insurance authorization or prescriber involvement for access. Relevant cost data:

• Brand (Excedrin): $8-$15 per 100 caplets
• Generic/store brand: $4-$8 per 100 caplets
• Per-dose cost: Approximately $0.08-$0.15 per dose (generic) or $0.16-$0.30 per dose (brand)

For patients with financial constraints, store-brand generics offer equivalent efficacy at significantly lower cost. HSA/FSA accounts can typically be used for OTC analgesics.

When patients report difficulty with cost, direct them to our savings guide: How to save money on Acetaminophen/Caffeine.

Tools and Resources for Your Practice

When patients report difficulty finding Acetaminophen/Caffeine, these resources can help:

Medfinder for Providers

Medfinder is a medication availability tool that helps both patients and providers locate medications in stock. You can recommend it to patients or use it yourself during clinical encounters to identify nearby pharmacies with supply.

Patient Education

Key messages to reinforce with patients:

1. Generic/store-brand Acetaminophen/Caffeine is clinically equivalent to Excedrin Tension Headache
2. Maximum 6 caplets (3,000 mg acetaminophen) per 24 hours
3. Avoid combining with other acetaminophen-containing products
4. Limit alcohol use while taking acetaminophen
5. Avoid excessive additional caffeine from beverages
6. Seek medical attention if headaches require OTC analgesics more than 2-3 times per week

When to Transition to Prescription Management

Consider transitioning patients to prescription headache management when:

• OTC analgesics are used more than 10-15 days per month
• Headache frequency or severity is increasing
• Patient reports functional impairment from headaches
• Medication overuse headache is suspected
• OTC options provide inadequate relief

For additional information on helping patients find this medication, see our provider guide: How to help your patients find Acetaminophen/Caffeine in stock.

Looking Ahead

The Acetaminophen/Caffeine market is stable with no anticipated disruptions. Multiple manufacturers, broad retail distribution, and low cost make this one of the most accessible OTC analgesics available. The primary challenges are patient-level — localized stock-outs, confusion about brand vs. generic equivalence, and the risk of medication overuse headache with chronic use.

Provider-level interventions that add the most value include reinforcing the generic equivalence message, screening for medication overuse headache, and directing patients to tools like Medfinder when they report difficulty finding their medication.

Final Thoughts

Acetaminophen/Caffeine remains widely available and affordable in 2026. There is no national shortage of oral formulations. When patients report difficulty finding it, the most likely causes are local stock issues or brand-specific preferences that can be addressed through education about generic equivalence and redirection to alternative retail sources.

For patient-facing resources, you can share our articles on how to find Acetaminophen/Caffeine in stock and alternatives to Acetaminophen/Caffeine.